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with the other induction drugs namely, vincristine, methotrexate,
decadron, Peg- Asparaginase, ARA-C, doxorubicin was continued.
On day 6 of therapy she developed fever, neutropenia and Bacil-
lus cereus bacteremia. For this broad spectrum antibiotics were
started but no antifungal prophylaxis was begun. During the next
week she developed progressive abdominal pain, rib pain, short-
ness of breath, malaise until on day 14 when RLL infiltrates were
noted on Chest X-Ray. Bronchoscopy was negative for fungal el-
ements. CT scan of chest and abdomen revealed massive hep-
atosplenic infarction and large RLL consolidation (see figure 1).
This was associated with a rapid rise in transaminases and hy-
perammonemia, elevated CRP (see table). Open lung and wedge
biopsy of liver was done revealing subtotal hemorrhagic necrosis
with widespread angioinvasive pleomorphic fungal hyphal forms
(figure 2). In the immediate postoperative period she developed
liver failure and succumbed to irreversible shock. Lung and liver
tissue cultures obtained during biopsy cultured positive for Mucor
species.
Figure 1. Note extensive areas of infarction of spleen and liver segments.
Table 1. Note rapid progression in laboratory values
Date CPK AST ALT T/D Bilirubin
11/3/07 286 53 171 2.1
11/7/07 6616 5075 5292 2.9/6.6
Figure 2. Note angioinvasive fungal hyphae.
Conclusions: This case reveals that mucor can rapidly and fulmi-
nantly invade large vessels and vital organs resulting in occlusive
ischemic damage. Clinicians should have a high index of suspicion
for early diagnosis and surgical intervention to prevent mortality.
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Background: Because of an outbreak of Extended Spectrum of Be-
talactamase producing (ESBL) E. coli and Klebsiella pneumonia
emerged in the Hospital, the routine use of fluoroquinolone pro-
phylaxis was questioned. To evaluate the use of fluoroquinolone
prophylaxis and as a background for further recommendations,
this retrospective study was performed in patients with acute
leukaemia after induction therapy at a single-centre. The aim was
to study if there were differences in the use of empiric antibacte-
rial therapy whether prophylaxis was given or not, fever episodes
and infections.
Methods: Fifty-nine episodes of neutropenia following induction
therapy for acute leukaemia were studied during the 2-year pe-
riod, from May 2004 until April 2006, consisting of 55 patients with
4 patients who had relapse of their disease during the study period
and underwent a new induction therapy. The study period was from
the start of induction therapy (day 0) until recovery of neutrophil
count > 0.5x109/L or if the neutrophils did not recover until the
initiation of new chemotherapy or death. Neutropenia was defined
as when neutrophils were <0.5x109/L. If ciprofloxacin prophylaxis
was given, the dose was 500 mg twice daily. For comparison be-
tween different groups the non-parametric Mann-Whitney U-test or
Chi squared test were used when appropriate. A p-value of <0.05
was regarded as statistically significant.
Results: When excluding 16 (27%) of 59 neutropenic periods
on intravenous antibiotics before initiation of induction therapy
(shown separately), 43 neutropenic episodes remained with 29 on
ciprofloxacin prophylaxis and 14 without. These groups matched
each other well. Ciprofloxacin prophylaxis delayed initiation of i.v.
empiric antibiotic therapy with more than 6 days (p<.002), re-
duced the total antibiotics used and days on i.v. antibiotic with
nine days (p<0.002), and febrile episodes (p<0.03). The use of
carbapenems was significantly reduced with 7 days (p<0.004).
The rate of initiating empiric antifungal agents was also reduced
(p<0.012).
Conclusion: In this retrospective single centre study we found that
ciprofloxacin prophylaxis delayed and reduced empiric antibiotic
use and febrile episodes. The results set an important question.
Which strategy is most harmful for the development of resistant
bacterial strains -fluoroquinolone prophylaxis or early initiation
and thus longer duration of empiric antibiotic therapy when no
prophylaxis is given.
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Background: Typhlitis, is a necrotizing inflammation of the colon,
almost invariably associated with underlying malignancy, intensive
chemotherapy, and severe neutropenia. Currently, limited data are
available on the incidence, outcome, and risk factors of typhlitis in
children with cancer. Previous studies addressing this issue did not
take into account the current changes in cancer treatment proto-
cols and were based on a limited number of cases.
Objectives: To define the epidemiological and clinical features of
